Teva Recalls Drugs With Probable Carcinogen

December 7, 2018

Teva Pharmaceuticals has recalled two drugs used to treat high blood pressure due to the presence of a probable human carcinogen, N-nitroso-diethylamine (NDEA).

The recall affects all lots of:

Amlodipine / Valsartan combination tablets
Amlodipine / Valsartan / Hydrochlorothiazide combination tablets

Pharmacies can contact Teva by phone at 888-838-2872, or email at druginfo@tevapharm.com.

View the full list of recalled products in the FDA press release.

Teva Recalls Drugs With Probable Carcinogen

Related

Archive